Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

113.23
Delayed Data
As of Apr 27
 -0.22 / -0.19%
Today’s Change
96.63
Today|||52-Week Range
177.93
+4.22%
Year-to-Date
Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?
Apr 25 / Zacks.com - Paid Partner Content
Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?
Apr 21 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?
Apr 25 / Zacks.com - Paid Partner Content
Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?
Apr 20 / Zacks.com - Paid Partner Content
Celgene (CELG) to Post Q1 Earnings: What's in the Cards?
Apr 24 / Zacks.com - Paid Partner Content
Allergan (AGN) Collaborates with Novartis to Treat NASH
Apr 19 / Zacks.com - Paid Partner Content
Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?
Apr 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close113.45
Today’s open113.75
Day’s range113.08 - 114.91
Volume222,881
Average volume (3 months)458,039
Market cap$2.8B
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)-75.10%
Earnings growth (this year)+1.86%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+796.87%
P/E ratioNM
Price/Sales107.40
Price/Book8.94

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-1.14-1.74%
SAGESAGE Therapeutics In...-0.44-0.61%
----
CLVSClovis Oncology Inc-0.43-0.73%
Data as of 04/27/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$4.36
Annual revenue (last year)$25.0M
Annual profit (last year)-$412.8M
Net profit margin-1,654.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts